Linagliptin
- Catalog NO.:A26901
- CAS No. : 668270-12-0
- Molecular Formula:C25H28N8O2
- Molecular Weight: 472.54
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 668270-12-0 | Appearance | yellow powder |
Catalog Number | A26901 | MDL Number | MFCD14635356 |
Molecular Formula | C25H28N8O2 | Molecular Weight | 472.54 |
Boiling Point | Melting Point | 202℃ | |
Flash Point | Density | ||
Synonyms | (R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H319-H332-H335 | Class | |
Precautionary Statements | P280-P305+P351+P338-P310 | Packing Group |
Description
Linagliptin, also known as BI-1356, is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. |